publication venue for Specific targeting of the NRF2/ß-TrCP axis promotes beneficial effects in NASH. 1-12. 2024 An inhibitor of interaction between the transcription factor NRF2 and the E3 ubiquitin ligase adapter beta-TrCP delivers anti-inflammatory responses in mouse liver. 1-17. 2022
